Transcriptome differences between the frontal cortex and hippocampus of wild-type and humanized Presenilin-1 transgenic mice

American Journal of Geriatric Psychiatry

Volumn 13, Issue 12, 2005, Pages 1041-1051

  Unger, Travis ^a   Korade, Zeljka ^b   Lazarov, Orly ^a   Terrano, David ^a   Schor, Nina F ^b   Sisodia, Sangram S ^a   Mirnics, Károly ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE; PRESENILIN 1; PROSTAGLANDIN D SYNTHASE; TRANSCRIPTOME; MEMBRANE PROTEIN; PSEN1 PROTEIN, HUMAN;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DNA MICROARRAY; FRONTAL CORTEX; GENE CLUSTER; GENE EXPRESSION; GENE MUTATION; HIPPOCAMPUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; TRANSGENIC MOUSE; UNINDEXED SEQUENCE; ANIMAL; DNA SEQUENCE; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; HUMAN; METABOLISM; POINT MUTATION;

ALZHEIMER DISEASE; ANIMALS; DATABASES, GENETIC; FRONTAL LOBE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HIPPOCAMPUS; HUMANS; MEMBRANE PROTEINS; MICE; MICE, TRANSGENIC; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POINT MUTATION; PRESENILIN-1; SEQUENCE ANALYSIS, DNA;

EID: 33645734421     PISSN: 10647481     EISSN: 15457214     Source Type: Journal    
DOI: 10.1097/00019442-200512000-00003     Document Type: Article

References (50)

1. Mirnics K, Levitt P, Lewis DA: DNA microarray analysis of post-mortem brain tissue. Int Rev Neurobiol 2004; 60:153-181
2. Lipshutz RJ, Fodor SP, Gingeras TR, et al: High-density synthetic oligonucleotide arrays. Nat Genet 1999; 21(suppl1):20-24
3. Lockhart DJ, Dong H, Byrne MC, et al: Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 1996; 14:1675-1680
4. Schena M, Shalon D, Davis RW, et al: Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270(5235):467-470
5. Geschwind DH, Ou J, Easterday MC, et al: A genetic analysis of neural progenitor differentiation. Neuron 2001; 29:325-339
6. Kamme F, Salunga R, Yu J, et al: Single-cell microarray analysis in hippocampus CA1: demonstration and validation of cellular heterogeneity. J Neurosci 2003; 23:3607-3615
7. Bonaventure P, Guo H, Tian B, et al: Nuclei and subnuclei gene expression profiling in mammalian brain. Brain Res 2002; 943:38-47
8. Sandberg R, Yasuda R, Pankratz DG, et al: Regional and strain-specific gene-expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A 2000; 97:11038-11043
9. Torres-Munoz JE, Van Waveren C, Keegan MG, et al: Gene-expression profiles in microdissected neurons from human hippocampal subregions. Brain Res Mol Brain Res 2004; 127:105-114
10. Mirnics ZK, Mirnics K, Terrano D, et al. DNA microarray profiling of developing PS1-deficient mouse brain reveals complex and coregulated expression changes. Mol Psychiatry 2003; 8:863-878
11. Yao WD, Gainetdinov RR, Arbuckle MI, et al: Identification of PSD-95 as a regulator of dopamine-mediated synaptic and behavioral plasticity. Neuron 2004; 41:625-638
12. McClung CA, Nestler EJ: Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci 2003; 6:1208-1215
13. Ginsberg SD, Hemby SE, Lee VM, et al: Expression profile of transcripts in Alzheimer's disease tangle-bearing CA1 neurons. Ann Neurol 2000; 48:77-87
14. Hemby SE, Ginsberg SD, Brunk B, et al: Gene-expression profile for schizophrenia: discrete neuron transcription patterns in the entorhinal cortex. Arch Gen Psychiatry 2002; 59:631-640
15. Loring JF, Wen X, Lee JM, et al: A gene-expression profile of Alzheimer's disease. DNA Cell Biol 2001; 20:683-695
16. Mao R, Zielke CL, Zielke HR, et al: Global up-regulation of Chromosome 21 gene expression in the developing Down syndrome brain. Genomics 2003; 81:457-467
17. Mirnics K, Middleton FA, Marquez A, et al: Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 2000; 28:53-67
18. Mirnics K, Middleton FA, Stanwood GD, et al: Disease-specific changes in regulator of G-protein signaling 4 (RGS4) expression in schizophrenia. Mol Psychiatry 2001; 6:293-301
19. Pasinetti GM: Use of cDNA microarray in the search for molecular markers involved in the onset of Alzheimer's disease dementia. J Neurosci Res 2001; 65:471-476
20. Colantuoni C, Jeon OH, Hyder K, et al: Gene-expression profiling in postmortem Rett syndrome brain: differential gene expression and patient classification. Neurobiol Dis 2001; 8:847-865
21. Blalock EM, Geddes JW, Chen KC, et al: Incipient Alzheimer's disease: microarray correlation analyses reveal major transcriptional and tumor suppressor responses. Proc Natl Acad Sci U S A 2004; 101:2173-2178
22. Mirnics K, Korade-Mirnics Z, Portugal CF, et al: Presenilin-1-dependent transcriptome changes. J Neurosci 2005; 25:(in press)
23. Lazarov O, Lee M, Peterson DA, et al: Evidence that synaptically released beta-amyloid accumulates as extracellular deposits in the hippocampus of transgenic mice. J Neurosci 2002; 22:9785-9793
24. Borchelt DR, Thinakaran G, Eckman CB, et al: Familial Alzheimer's disease-linked presenilin-1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo. Neuron 1996; 17:1005-1013
25. Borchelt DR, Ratovitski T, van Lare J, et al: Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin-1 and amyloid precursor proteins. Neuron 1997; 19:939-945
26. Borchelt DR, Davis J, Fischer M, et al: A vector for expressing foreign genes in the brains and hearts of transgenic mice. Biomol Eng (Genet Anal) 1996; 13:159-163
27. Lee MK, Borchelt DR, Kim G, et al: Hyperaccumulation of FAD-linked presenilin-1 variants in vivo. Nat Med 1997; 3:756-760
28. Thinakaran G, Borchelt DR, Lee MK, et al: Endoproteolysis of presenilin-1 and accumulation of processed derivatives in vivo. Neuron 1996; 17:181-190
29. Irizarry RA, Hobbs B, Collin F, et al: Exploration, normalization, and summaries of high-density oligonucleotide array probe-level data. Biostatistics 2003; 4:249-264
30. Irizarry RA, Bolstad BM, Collin F, et al: Summaries of Affymetrix GeneChip probe-level data. Nucleic Acids Res 2003; 31:e15
31. Eisen MB, Spellman PT, Brown PO, et al: Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95:14863-14868
32. Lepre J, Rice JJ, Tu Y, et al: Genes@Work: an efficient algorithm for pattern discovery and multivariate feature selection in gene-expression data. Bioinformatics 2004; 20:1033-1044
33. Pavlidis P, Noble WS: Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol 2001; 2:RESEARCH0042
34. Su AI, Wiltshire T, Batalov S, et al: A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci U S A 2004; 101:6062-6067
35. Griffin RS, Mills CD, Costigan M, et al: Exploiting microarrays to reveal differential gene expression in the nervous system. Genome Biol 2003; 4:105
36. Bodmer S, Podlisny MB, Selkoe DJ, et al: Transforming growth factor-beta bound to soluble derivatives of the beta-amyloid precursor protein of Alzheimer's disease. Biochem Biophys Res Commun 1990; 171:890-897
37. Peress NS, Perillo E: Differential expression of TGF-beta 1, 2, and 3 isotypes in Alzheimer's disease: a comparative immunohistochemical study with cerebral infarction, aged human, and mouse control brains. J Neuropathol Exp Neurol 1995; 54:802-811
38. Flanders KC, Lippa CF, Smith TW, et al: Altered expression of transforming growth factor-beta in Alzheimer's disease. Neurology 1995; 45:1561-1569
39. Farooqui AA, Liss L, Horrocks LA: Stimulation of lipolytic enzymes in Alzheimer's disease. Ann Neurol 1988; 23:306-308
40. Baum L, Chen L, Masliah E, et al: Lipoprotein lipase mutations and Alzheimer's disease. Am J Med Genet 1999; 88:136-139
41. Tham A, Nordberg A, Grissom FE, et al: Insulin-like growth factors and insulin-like growth factor-binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type. J Neural Transm Park Dis Dement Sect 1993; 5:165-176
42. Ikonen M, Liu B, Hashimoto Y, et al: Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis. Proc Natl Acad Sci U S A 2003; 100:13042-13047
43. Smith SK, Anderson HA, Yu G, et al: Identification of syntaxin-1A as a novel binding protein for presenilin-1. Brain Res Mol Brain Res 2000; 78:100-107
44. Dickey CA, Loring JF, Montgomery J, et al: Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice. J Neurosci 2003; 23:5219-5226
45. Cheon MS, Fountoulakis M, Cairns NJ, et al: Decreased protein levels of stathmin in adult brains with Down syndrome and Alzheimer's disease. J Neural Transm Suppl 2001:281-288
46. Jin LW, Masliah E, Iimoto D, et al: Neurofibrillary tangle-associated alteration of stathmin in Alzheimer's disease. Neurobiol Aging 1996; 17:331-341
47. Fountoulakis M, Cairns N, Lubec G: Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. J Neural Transm Suppl 1999; 57:323-335
48. Wbng PT, McGeer PL, McGeer EG: Decreased prostaglandin synthesis in postmortem cerebral cortex from patients with Alzheimer's disease. Neurochem Int 1992; 21:197-202
49. 1-42 oligomers. J Neurochem 2002; 82:1003-1006
50. Reddy PH, McWeeney S, Park BS, et al: Gene-expression profiles of transcripts in amyloid precursor protein transgenic mice: up-regulation of mitochondrial metabolism and apoptotic genes is an early cellular change in Alzheimer's disease. Hum Mol Genet 2004; 13:1225-1240